Physician profile

Mujtaba M Ali

Vascular Surgery · Dallas, TX

NPI 1851612592

$7,308.75

in general payments reported to CMS, 2019-2025

34 companies · $1,295 in 2025

The $1,295 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,531.19
Travel and Lodging$2,517.04
Consulting Fee$350.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic, INC. $1,915.67 2021-2025 Ellipsys Vascular Access System, Mo.Ma Ultra, Avalus
W. L. Gore & Associates, INC. $1,133.36 2019-2023 Gore Tag Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Excluder Iliac Branch Endoprosthesis
Angiodynamics, INC. $1,041.15 2024-2025 Auryon Laser System 100-120 Vac
Silk Road Medical, INC. $451.90 2019-2024 Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter
Cvrx, INC. $393.16 2023-2024 Barostim Neo System
Endologix LLC $362.32 2019-2022
Bolton Medical INC $344.80 2022-2024 Treo Abdominal Stent-Graft System
Penumbra, INC. $278.84 2022-2023 Penumbra System
Boston Scientific Corporation $207.60 2022-2025 Seismiq Lithotrip_pi, Angiojet Xmi, Jetstream Sc
Koya Medical, INC. $185.51 2025 Koya Medical, Dayspring
Shockwave Medical, INC $155.19 2020-2025 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Atricure, INC. $113.88 2022-2025 Synergy Ablation System, Atricure Cryoice Cryosphere Cryoablation System
Cardinal Health 200 LLC $77.60 2019
Boehringer Ingelheim Pharmaceuticals, INC. $73.27 2023-2024 Jardiance
Lemaitre Vascular, INC. $56.79 2023-2024 Artegraft Vascular Graft, Restoreflow
Show all 34 companies
CompanyGeneral paymentsYearsTop products
Getinge USA Sales, LLC $54.17 2025 Cardioroot
Tactile Systems Technology INC $49.95 2023-2025 Flexitouch Plus, Entre Plus, Nimbl
Abbott Laboratories $45.99 2023-2024 Esprit, Jeti Peripheral Catheter
Access Pro Medical, LLC $41.65 2023 Matriderm
Artivion, INC. $34.65 2022
Daiichi Sankyo INC. $28.73 2023 Injectafer
Scpharmaceuticals INC. $28.00 2024
Philips North America LLC $27.18 2024 (Ck4) Mcot
Bard Peripheral Vascular, INC. $26.57 2023 Rotarexs 6 F X 135 Cm
Innovation Technologies INC $24.84 2024 Irrisept
Surmodics, INC. $21.99 2022
Limflow INC. $21.09 2023 Limflow System
Baylis Medical Technologies INC. $20.50 2024
Baxter Healthcare $17.68 2025 Perclot
Argon Medical Devices, INC. $17.42 2025 Clot Management
Teleflex LLC $16.79 2022
Ethicon US, LLC $14.94 2022
Lsi Solutions INC $14.51 2019
Medtronic Vascular, INC. $11.06 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Mujtaba M Ali

$7,308.75

in general payments reported 2019-2025

Years
2019-2025
Top company
Medtronic, INC.
Context
The $1,295 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).

https://glasscript.com/doctor/985837/mujtaba-m-ali

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.